News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Bayer Diagnostics India Ltd. To Consider Sale Of Diabetes Unit
July 21, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUMBAI, July 21 (Reuters) - Medical equipment maker Bayer Diagnostics India Ltd. said on Friday its board would meet on July 25 to consider sale of its diabetes monitoring business to a Bayer group company.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
MORE ON THIS TOPIC
Psychedelics
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
July 24, 2026
·
3 min read
·
Gabrielle Masson
Job Trends
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
July 23, 2026
·
4 min read
·
Angela Gabriel
Manufacturing
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
July 22, 2026
·
2 min read
·
Nick Paul Taylor
China
US ‘eroding’ lead in rare diseases a matter of national security: Report
July 22, 2026
·
4 min read
·
Tristan Manalac
